Vaněčková, Ivana <br/><br/>
Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.  [electronic resource] 

 -  Kidney & blood pressure research  2012 
 - 382-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0143 
<br/><br/><label>Standard No.: </label>10.1159/000336823  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Atrasentan<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Endothelin A Receptor Antagonists<br/>Hypertension, Renal--drug therapy<br/>Indoles--pharmacology<br/>Kidney--pathology<br/>Losartan--pharmacology<br/>Male<br/>Nephrectomy--methods<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Transgenic<br/>Receptor, Angiotensin, Type 1--metabolism<br/>Receptor, Endothelin A--metabolism<br/>Renal Insufficiency, Chronic--drug therapy<br/>Renin-Angiotensin System--drug effects<br/>Survival Analysis<br/>Treatment Outcome